Unlock instant, AI-driven research and patent intelligence for your innovation.

Brucella genetic engineering subunit vaccine and preparation method and application thereof

A Brucella and subunit vaccine technology, applied in the field of Brucella genetically engineered subunit vaccine and its preparation, can solve the problems of infectivity, poor safety, and inability to inoculate pregnant animals in humans and animals, and achieve prevention Effect of Brucella infection, good immunogenicity

Pending Publication Date: 2021-09-07
CHONGQING ACAD OF ANIMAL SCI +1
View PDF9 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But the application of these three kinds of vaccines all has deficiencies: (1) poor safety, can not be inoculated in pregnant animals, breeding animals, dairy animals; (2) vaccinated animals cannot be distinguished from animals infected with wild virus; (3) vaccines are harmful to humans and animals. Infectious, endangering public health safety
The above-mentioned deficiencies have limited the scope of vaccine application, and cannot be used for breeding animals and dairy animals.
As a result, most areas can only control the prevalence of brucellosis through surveillance and culling, continuing a safe and effective brucellosis vaccine

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Brucella genetic engineering subunit vaccine and preparation method and application thereof
  • Brucella genetic engineering subunit vaccine and preparation method and application thereof
  • Brucella genetic engineering subunit vaccine and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0039] The construction of embodiment 1 recombinant expression vector

[0040] Bioinformatic analysis was carried out on the amino acid sequences of the outer membrane proteins OMP2, OMP25, OMP31, OMP28, and OMP22 proteins of the cattle, sheep, sheep testis, pigs, and canis Brucella from Genebank. The following antigenic epitopes were screened from Bacillus outer membrane protein: 22-51, 144-158 of goat Omp2a protein (GenBank: AMM72580.1); 233-245 of goat Omp2b protein (GenBank: AMM72579.1) Position, 314-336; 4-29 position of bovine Omp2b protein (GenBank: AAX94577.1); 41-53 position of pig Omp2b protein (GenBank: AAX94574.1); bovine Omp25 protein (GenBank: AFJ79953.1 ) 4-46, 187-197, 143-154; canine Omp25 protein (GenBank: CDL76104.1) 87-94; pig Omp25 protein (GenBank: AHN46339.1) 120-137 ; 10-27 positions of sheep testis Omp25 protein (GenBank: ABU93464.1) 19-27 positions of sheep Omp31 protein (GenBank: ACS50328.1); 4-14 positions of dog Omp31 protein (GenBank: AAL27296.1)...

Embodiment 2

[0046] Example 2 Plasmid Stability Identification

[0047] Escherichia coli B121 cells were selected as host bacteria, and the recombinant pET28a-MutiE expression vector constructed in Example 1 was transformed into Escherichia coli B121 competent cells by heat shock method, and then genetically engineered strains with stable and high expression of MutiE protein were screened. The specific steps are as follows: ①Thaw 100 μL of the prepared competent E. coli Bl21 cells on ice, and then add 1.5 μg of the prepared pET28a-MutiE vector; ②After mixing, place on ice for 30 minutes, and bathe in water at 45°C for 90 seconds; ③On ice Leave it for 3 minutes, add 700 μL LB medium, and activate at 37°C for 1 hour; ④Spread the activated bacterial solution on an LB solid plate with a kanamycin concentration of 100 μg / mL, and culture it upside down at 37°C overnight; ⑤Randomly select plump After numbering, they were inoculated in 5 mL LB liquid medium with a kanamycin concentration of 100 μg...

Embodiment 3

[0048] Example 3 Seed Bank Establishment

[0049] Establishment of the original seed bank: Take the strains prepared in Example 2 and insert them into 1.5mL LB medium with a kanamycin concentration of 100 μg / mL at a subsequent amount of 1%, and carry out shaking culture at 37°C to OD 600 Reached around 0.8. Then the culture solution was inoculated on LB solid plates with a kanamycin concentration of 100 μg / mL by streaking method, and cultured upside down at 37° C. overnight. Randomly select plump single colonies, number them and inoculate them in 5 mL of LB medium with a kanamycin concentration of 100 μg / mL, and culture with shaking at 37°C. Mix the bacterial solution cultivated to the logarithmic phase with the lyoprotectant at a ratio of 1:1, then take 3mL in a sterile 10mL vial under aseptic conditions, freeze-dry, and name it as the Brucella Genetic Engineering Subunit The original seed of the vaccine, the PCR identification result is as follows figure 1 shown.

[0050...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a Brucella genetic engineering subunit vaccine and a preparation method and application thereof, in particular to tandem epitope protein of a prokaryotically expressed Brucella outer membrane protein. The Brucella genetic engineering subunit vaccine comprises antigen epitopes of an OMP2 protein in a second group of outer membrane proteins (OMP2) and OMP25, OMP31, OMP28 and OMP22 proteins in a third group of outer membrane proteins of B.abortus, B.mellensis, B.suis and B.canis. The vaccine has good safety and effectiveness, and a good antibody level can be stimulated after cattle and sheep are subjected to intramuscular or subcutaneous injection.

Description

technical field [0001] The invention relates to the technical field of biopharmaceuticals, and relates to a brucella genetic engineering subunit vaccine and a preparation method and application thereof. Background technique [0002] Brucella is a Gram-negative intracellular parasite. Currently, there are 9 species of Brucella confirmed, of which 7 species host terrestrial animals, namely bovine species (B. abortus ), sheep (B.melitensis), pig (B.suis), sheep testicle (B.ovis), dog (B.canis), sandrat (B.neotomae) and voles (B. microti). There are 2 species of marine animals as the host, namely whale species (B. ceti) and seal species (B. pinnipedialis). Among them, Brucella of sheep, cattle, pig, and canis is a pathogen with strong transmissibility and a wide range of hosts, especially Brucella of sheep is the most pathogenic, and can pass through the skin, oral cavity, Mucous membranes, mating into animals, infection, and diseased individuals can spread to the outside of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00C12N15/70C12N1/21C07K16/12A61K39/02A61K9/19A61K47/46A61P31/04C12R1/19
CPCC07K14/23C12N15/70C07K16/1221A61K39/098A61K9/19A61K9/0019A61K47/46A61P31/04C07K2319/00A61K2039/552
Inventor 曹政付文贵付利芝何丹鲍伟穆德龙张月龙小玲
Owner CHONGQING ACAD OF ANIMAL SCI